{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:59:59Z","timestamp":1792745999284,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK114036"],"award-info":[{"award-number":["DK114036"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK130892"],"award-info":[{"award-number":["DK130892"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK136592"],"award-info":[{"award-number":["DK136592"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK127984"],"award-info":[{"award-number":["P30DK127984"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK070332"],"award-info":[{"award-number":["DK070332"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["S10OD025203"],"award-info":[{"award-number":["S10OD025203"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["23POST1019715"],"award-info":[{"award-number":["23POST1019715"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24CDA1257999"],"award-info":[{"award-number":["24CDA1257999"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76561-w","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:02:49Z","timestamp":1788426169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional coupling between MC4R and Kir7.1 contributes to clozapine-induced weight gain in female mice"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8173-7367","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciria C.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0110-2135","authenticated-orcid":false,"given":"Luis E.","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima S.","family":"Dahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-5440","authenticated-orcid":false,"given":"Alys","family":"Peisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1963-4877","authenticated-orcid":false,"given":"Alexandra","family":"Serrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Swati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-0310","authenticated-orcid":false,"given":"Shari G.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3333-5651","authenticated-orcid":false,"given":"Roger D.","family":"Cone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-0951","authenticated-orcid":false,"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"76561_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","volume":"64","author":"HY Meltzer","year":"2013","unstructured":"Meltzer, H. Y. Update on typical and atypical antipsychotic drugs. Annu. Rev. Med. 64, 393\u2013406 (2013).","journal-title":"Annu. Rev. Med."},{"key":"76561_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fpsyt.2012.00062","volume":"3","author":"JM Gohlke","year":"2012","unstructured":"Gohlke, J. M. et al. Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front. Psychiatry 3, 62 (2012).","journal-title":"Front. Psychiatry"},{"key":"76561_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/s-0028-1085438","volume":"42","author":"T Baptista","year":"2009","unstructured":"Baptista, T. et al. Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial. Pharmacopsychiatry 42, 14\u201319 (2009).","journal-title":"Pharmacopsychiatry"},{"key":"76561_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/070674370605100310","volume":"51","author":"T Baptista","year":"2006","unstructured":"Baptista, T. et al. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial. Can. J. Psychiatry 51, 192\u2013196 (2006).","journal-title":"Can. J. Psychiatry"},{"key":"76561_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0924-977X(02)00127-X","volume":"13","author":"P Cavazzoni","year":"2003","unstructured":"Cavazzoni, P., Tanaka, Y., Roychowdhury, S. M., Breier, A. & Allison, D. B. Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial. Eur. Neuropsychopharmacol. 13, 81\u201385 (2003).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"76561_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2020","unstructured":"Kaar, S. J., Natesan, S., McCutcheon, R. & Howes, O. D. Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology 172, 107704 (2020).","journal-title":"Neuropharmacology"},{"key":"76561_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopsych.2023.04.004","volume":"94","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon, R. A. et al. Data-driven taxonomy for antipsychotic medication: a new classification system. Biol. Psychiatry 94, 561\u2013568 (2023).","journal-title":"Biol. Psychiatry"},{"key":"76561_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.euroneuro.2025.07.011","volume":"99","author":"C Lange-Asschenfeldt","year":"2025","unstructured":"Lange-Asschenfeldt, C., Brouzou, K. & Christl, J. Comparative receptor pharmacology of antipsychotic drugs based on normalized binding affinity data and breadth of interaction. Eur. Neuropsychopharmacol. 99, 31\u201340 (2025).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"76561_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","volume":"172","author":"HY Meltzer","year":"2008","unstructured":"Meltzer, H. Y. & Huang, M. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog. Brain Res. 172, 177\u2013197 (2008).","journal-title":"Prog. Brain Res."},{"key":"76561_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nurt.2008.10.020","volume":"6","author":"DH Kim","year":"2009","unstructured":"Kim, D. H., Maneen, M. J. & Stahl, S. M. Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia. Neurotherapeutics 6, 78\u201385 (2009).","journal-title":"Neurotherapeutics"},{"key":"76561_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pnpbp.2018.01.023","volume":"84","author":"B Olten","year":"2018","unstructured":"Olten, B. & Bloch, M. H. Meta regression: relationship between antipsychotic receptor binding profiles and side-effects. Prog. Neuropsychopharmacol. Biol. Psychiatry 84, 272\u2013281 (2018).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"76561_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","volume":"125","author":"GP Reynolds","year":"2010","unstructured":"Reynolds, G. P. & Kirk, S. L. Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms. Pharm. Ther. 125, 169\u2013179 (2010).","journal-title":"Pharm. Ther."},{"key":"76561_CR13","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","volume":"16","author":"S Siafis","year":"2018","unstructured":"Siafis, S., Tzachanis, D., Samara, M. & Papazisis, G. Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr. Neuropharmacol. 16, 1210\u20131223 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"76561_CR14","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1172\/JCI93362","volume":"127","author":"CC Lord","year":"2017","unstructured":"Lord, C. C. et al. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. J. Clin. Invest. 127, 3402\u20133406 (2017).","journal-title":"J. Clin. Invest."},{"key":"76561_CR15","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1073\/pnas.0611417104","volume":"104","author":"SF Kim","year":"2007","unstructured":"Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C. & Snyder, S. H. From the cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc. Natl. Acad. Sci. USA 104, 3456\u20133459 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76561_CR16","doi-asserted-by":"publisher","unstructured":"Li, L. et al. The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain. J. Exp. Med. 218 https:\/\/doi.org\/10.1084\/jem.20202484 (2021).","DOI":"10.1084\/jem.20202484"},{"key":"76561_CR17","doi-asserted-by":"publisher","unstructured":"Su, Y. et al. Olanzapine modulate lipid metabolism and adipose tissue accumulation via hepatic muscarinic M3 receptor-mediated Alk-related signaling. Biomedicines 12 https:\/\/doi.org\/10.3390\/biomedicines12071403 (2024).","DOI":"10.3390\/biomedicines12071403"},{"key":"76561_CR18","doi-asserted-by":"publisher","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","volume":"6","author":"J Ferno","year":"2011","unstructured":"Ferno, J. et al. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS ONE 6, e20571 (2011).","journal-title":"PLoS ONE"},{"key":"76561_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/cns.13281","volume":"26","author":"XQ Wan","year":"2020","unstructured":"Wan, X. Q. et al. Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5-HT2c receptor-NPY pathway. CNS Neurosci. Ther. 26, 558\u2013566 (2020).","journal-title":"CNS Neurosci. Ther."},{"key":"76561_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-020-01582-9","author":"M Pozzi","year":"2020","unstructured":"Pozzi, M. et al. Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression. Eur. Child Adolesc. Psychiatry https:\/\/doi.org\/10.1007\/s00787-020-01582-9 (2020).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"76561_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0278-5846(01)00266-4","volume":"26","author":"G Kaur","year":"2002","unstructured":"Kaur, G. & Kulkarni, S. K. Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 277\u2013285 (2002).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"76561_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/npp.2017.20","volume":"42","author":"A Rimessi","year":"2017","unstructured":"Rimessi, A. et al. Protein kinase C beta: a new target therapy to prevent the long-term atypical antipsychotic-induced weight gain. Neuropsychopharmacology 42, 1491\u20131501 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"76561_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"76561_CR24","first-page":"42","volume":"36","author":"A Karampas","year":"2025","unstructured":"Karampas, A. et al. Clozapine\/norclozapine plasma concentrations and their ratio in treatment resistant, early psychosis patients. Psychiatriki 36, 42\u201354 (2025).","journal-title":"Psychiatriki"},{"key":"76561_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade8460","volume":"15","author":"S Zhao","year":"2023","unstructured":"Zhao, S. et al. Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders. Sci. Transl. Med. 15, eade8460 (2023).","journal-title":"Sci. Transl. Med."},{"key":"76561_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-01981-9","author":"RC Zapata","year":"2023","unstructured":"Zapata, R. C. et al. Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-023-01981-9 (2023).","journal-title":"Mol. Psychiatry"},{"key":"76561_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/tpj.2011.66","volume":"13","author":"NI Chowdhury","year":"2013","unstructured":"Chowdhury, N. I. et al. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene. Pharmacogenomics J. 13, 272\u2013279 (2013).","journal-title":"Pharmacogenomics J."},{"key":"76561_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ajmg.b.20169","volume":"134B","author":"VL Ellingrod","year":"2005","unstructured":"Ellingrod, V. L. et al. Weight gain associated with the -759C\/T polymorphism of the 5HT2C receptor and olanzapine. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 76\u201378 (2005).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"76561_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/ajmg.b.30311","volume":"141B","author":"YM Park","year":"2006","unstructured":"Park, Y. M. et al. Weight gain associated with the alpha2a-adrenergic receptor -1,291 C\/G polymorphism and olanzapine treatment. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 394\u2013397 (2006).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"76561_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/archgenpsychiatry.2012.191","volume":"69","author":"AK Malhotra","year":"2012","unstructured":"Malhotra, A. K. et al. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch. Gen. Psychiatry 69, 904\u2013912 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"76561_CR31","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","volume":"42","author":"JP Zhang","year":"2016","unstructured":"Zhang, J. P. et al. Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr. Bull. 42, 1418\u20131437 (2016).","journal-title":"Schizophr. Bull."},{"key":"76561_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.schres.2019.07.022","volume":"212","author":"M Maciukiewicz","year":"2019","unstructured":"Maciukiewicz, M. et al. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Schizophr. Res. 212, 204\u2013212 (2019).","journal-title":"Schizophr. Res."},{"key":"76561_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1359786806066040","volume":"20","author":"GP Reynolds","year":"2006","unstructured":"Reynolds, G. P., Hill, M. J. & Kirk, S. L. The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics. J. Psychopharmacol. 20, 15\u201318 (2006).","journal-title":"J. Psychopharmacol."},{"key":"76561_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41574-023-00855-y","volume":"19","author":"P Sweeney","year":"2023","unstructured":"Sweeney, P., Gimenez, L. E., Hernandez, C. C. & Cone, R. D. Targeting the central melanocortin system for the treatment of metabolic disorders. Nat. Rev. Endocrinol. 19, 507\u2013519 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"76561_CR35","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1021\/jm9017866","volume":"53","author":"MI Lansdell","year":"2010","unstructured":"Lansdell, M. I. et al. Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans. J. Med. Chem. 53, 3183\u20133197 (2010).","journal-title":"J. Med. Chem."},{"key":"76561_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1021\/cb200248h","volume":"6","author":"BF Binkowski","year":"2011","unstructured":"Binkowski, B. F. et al. A luminescent biosensor with increased dynamic range for intracellular cAMP. ACS Chem. Biol. 6, 1193\u20131197 (2011).","journal-title":"ACS Chem. Biol."},{"key":"76561_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nn.4011","volume":"18","author":"AS Garfield","year":"2015","unstructured":"Garfield, A. S. et al. A neural basis for melanocortin-4 receptor-regulated appetite. Nat. Neurosci. 18, 863\u2013871 (2015).","journal-title":"Nat. Neurosci."},{"key":"76561_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.neuron.2019.02.028","volume":"102","author":"MM Li","year":"2019","unstructured":"Li, M. M. et al. The paraventricular hypothalamus regulates satiety and prevents obesity via two genetically distinct circuits. Neuron 102, 653\u2013667 e656 (2019).","journal-title":"Neuron"},{"key":"76561_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger, T. et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry 7, 64\u201377 (2020).","journal-title":"Lancet Psychiatry"},{"key":"76561_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14051","volume":"520","author":"M Ghamari-Langroudi","year":"2015","unstructured":"Ghamari-Langroudi, M. et al. G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons. Nature 520, 94\u201398 (2015).","journal-title":"Nature"},{"key":"76561_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12670","volume":"31","author":"EJP Anderson","year":"2019","unstructured":"Anderson, E. J. P. et al. Late onset obesity in mice with targeted deletion of potassium inward rectifier Kir7.1 from cells expressing the melanocortin-4 receptor. J. Neuroendocrinol. 31, e12670 (2019).","journal-title":"J. Neuroendocrinol."},{"key":"76561_CR42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.aaz8995","volume":"368","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. Determination of the melanocortin-4 receptor structure identifies Ca(2+) as a cofactor for ligand binding. Science 368, 428\u2013433 (2020).","journal-title":"Science"},{"key":"76561_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/2211068215623209","volume":"21","author":"A Obergrussberger","year":"2016","unstructured":"Obergrussberger, A. et al. Automated patch clamp meets high-throughput screening: 384 cells recorded in parallel on a planar patch clamp module. J. Lab Autom. 21, 779\u2013793 (2016).","journal-title":"J. Lab Autom."},{"key":"76561_CR44","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1021\/acs.jmedchem.3c01822","volume":"67","author":"LE Gimenez","year":"2024","unstructured":"Gimenez, L. E. et al. Novel cocrystal structures of peptide antagonists bound to the human melanocortin receptor 4 unveil unexplored grounds for structure-based drug design. J. Med. Chem. 67, 2690\u20132711 (2024).","journal-title":"J. Med. Chem."},{"key":"76561_CR45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1021\/acschemneuro.6b00111","volume":"7","author":"DR Swale","year":"2016","unstructured":"Swale, D. R. et al. ML418: the first selective, sub-micromolar pore blocker of Kir7.1 potassium channels. ACS Chem. Neurosci. 7, 1013\u20131023 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"76561_CR46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00213-012-2860-4","volume":"225","author":"AE Van Swearingen","year":"2013","unstructured":"Van Swearingen, A. E., Walker, Q. D. & Kuhn, C. M. Sex differences in novelty- and psychostimulant-induced behaviors of C57BL\/6 mice. Psychopharmacology 225, 707\u2013718 (2013).","journal-title":"Psychopharmacology"},{"key":"76561_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00491982","volume":"65","author":"DS Janowsky","year":"1979","unstructured":"Janowsky, D. S. & Risch, C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology 65, 73\u201377 (1979).","journal-title":"Psychopharmacology"},{"key":"76561_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00427592","volume":"67","author":"B Angrist","year":"1980","unstructured":"Angrist, B., Rotrosen, J. & Gershon, S. Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. Psychopharmacology 67, 31\u201338 (1980).","journal-title":"Psychopharmacology"},{"key":"76561_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0014-2999(03)01308-6","volume":"462","author":"HO Kalkman","year":"2003","unstructured":"Kalkman, H. O. & Loetscher, E. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur. J. Pharm. 462, 33\u201340 (2003).","journal-title":"Eur. J. Pharm."},{"key":"76561_CR50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.yjmcc.2005.01.007","volume":"38","author":"S Haider","year":"2005","unstructured":"Haider, S., Antcliff, J. F., Proks, P., Sansom, M. S. & Ashcroft, F. M. Focus on Kir6.2: a key component of the ATP-sensitive potassium channel. J. Mol. Cell Cardiol. 38, 927\u2013936 (2005).","journal-title":"J. Mol. Cell Cardiol."},{"key":"76561_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12325-018-0824-8","volume":"36","author":"CM Apovian","year":"2019","unstructured":"Apovian, C. M., Okemah, J. & O\u2019Neil, P. M. Body weight considerations in the management of type 2 diabetes. Adv. Ther. 36, 44\u201358 (2019).","journal-title":"Adv. Ther."},{"key":"76561_CR52","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature04711","volume":"440","author":"CG Nichols","year":"2006","unstructured":"Nichols, C. G. KATP channels as molecular sensors of cellular metabolism. Nature 440, 470\u2013476 (2006).","journal-title":"Nature"},{"key":"76561_CR53","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","volume":"108","author":"JL Miller","year":"2023","unstructured":"Miller, J. L. et al. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: a double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 108, 1676\u20131685 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76561_CR54","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00213-019-05425-7","volume":"237","author":"AR Abela","year":"2020","unstructured":"Abela, A. R., Ji, X. D., Li, Z., Le, A. D. & Fletcher, P. J. Clozapine reliably increases the motivation for food: parsing the role of the 5-HT(2c) and H(1) receptors. Psychopharmacology 237, 957\u2013966 (2020).","journal-title":"Psychopharmacology"},{"key":"76561_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.exer.2018.07.014","volume":"176","author":"D Roman","year":"2018","unstructured":"Roman, D., Zhong, H., Yaklichkin, S., Chen, R. & Mardon, G. Conditional loss of Kcnj13 in the retinal pigment epithelium causes photoreceptor degeneration. Exp. Eye Res. 176, 219\u2013226 (2018).","journal-title":"Exp. Eye Res."},{"key":"76561_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith, P. K. et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76\u201385 (1985).","journal-title":"Anal. Biochem."},{"key":"76561_CR57","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng, Y. & Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099\u20133108 (1973).","journal-title":"Biochem. Pharmacol."},{"key":"76561_CR58","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.1021\/acs.jmedchem.1c01295","volume":"65","author":"LE Gimenez","year":"2022","unstructured":"Gimenez, L. E. et al. Demonstration of a common DPhe(7) to DNal(2\u2019)(7) peptide ligand antagonist switch for melanocortin-3 and melanocortin-4 receptors identifies the systematic mischaracterization of the pharmacological properties of melanocortin peptides. J. Med. Chem. 65, 5990\u20136000 (2022).","journal-title":"J. Med. Chem."},{"key":"76561_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr6459","volume":"17","author":"B Xu","year":"2025","unstructured":"Xu, B. et al. Orthopedia regulates melanocortin 4 receptor transcription and energy homeostasis. Sci. Transl. Med. 17, eadr6459 (2025).","journal-title":"Sci. Transl. Med"},{"key":"76561_CR60","doi-asserted-by":"publisher","unstructured":"Li, L. et al. Delineating a serotonin 1B receptor circuit for appetite suppression in mice. J. Exp. Med. 219 https:\/\/doi.org\/10.1084\/jem.20212307 (2022).","DOI":"10.1084\/jem.20212307"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76561-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:02:51Z","timestamp":1788426171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76561"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76561-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.D.C., L.E.G., and the University of Michigan have equity in Courage Therapeutics, and R.D.C. serves on the company board. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9139"}}